⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DARE News
Dare Bioscience, Inc. Common Stock
Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive
globenewswire.com
DARE
Form 8-K
sec.gov
DARE
Daré Bioscience to Host First Quarter 2026 Financial Results and Company Update Conference Call and Webcast on May 14, 2026
globenewswire.com
DARE
Form 8-K
sec.gov
DARE
Form 8-K
sec.gov
DARE
Form 8-K
sec.gov
DARE
Form 8-K
sec.gov
DARE
Form 8-K
sec.gov
DARE
Daré Bioscience Reports Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
DARE
On National Viagra Day, Women Finally Claim Their Turn:
globenewswire.com
DARE